Background: The highest mortality and morbidity worldwide is associated with atherosclerotic cardiovascular disease (ASCVD), which has in background both environmental and genetic risk factors. Apolipoprotein L1 (APOL1) variability influences the risk of ASCVD in Africans, but little is known about the APOL1 and ASCVD in other ethnic groups.
Methods: To investigate the role of APOL1 and ASCVD, we have genotyped four (rs13056427, rs136147, rs10854688 and rs9610473) APOL1 polymorphisms in a group of 1541 male patients with acute coronary syndrome (ACS) and 1338 male controls.
Results: Individual APOL1 polymorphisms were not associated with traditional CVD risk factors such as smoking, hypertension or diabetes prevalence, with BMI values or plasma lipid levels. Neither individual polymorphisms nor haplotypes were associated with an increased risk of ACS nor did they predict total or cardiovascular mortality over the 10.2 ± 3.9 years of follow-up.
Conclusions: We conclude that APOL1 genetic variability has no major effect on risk of ACS in Caucasians.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339648 | PMC |
| http://dx.doi.org/10.1002/mgg3.2449 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Viral Nephropathies: Core Curriculum 2024.
Am J Kidney Dis
December 2024
Division of Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Article Synopsis
- - Viral-associated nephropathy is kidney disease that arises from viral infections, most notably from viruses like hepatitis B, hepatitis C, HIV, and SARS-CoV-2, with different prevalence depending on immune status.
- - The kidney damage can result from direct viral infection or indirect immune responses, affecting structures like glomeruli and tubules, and sometimes linked to other conditions like liver dysfunction.
- - Recent advancements in understanding these conditions, including genetic factors and antiviral treatments, aim to improve management and reduce complications related to viral nephropathies.
APOL1 polymorphisms are not influencing acute coronary syndrome risk in Czech males.
Mol Genet Genomic Med
August 2024
Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Background: The highest mortality and morbidity worldwide is associated with atherosclerotic cardiovascular disease (ASCVD), which has in background both environmental and genetic risk factors. Apolipoprotein L1 (APOL1) variability influences the risk of ASCVD in Africans, but little is known about the APOL1 and ASCVD in other ethnic groups.
Methods: To investigate the role of APOL1 and ASCVD, we have genotyped four (rs13056427, rs136147, rs10854688 and rs9610473) APOL1 polymorphisms in a group of 1541 male patients with acute coronary syndrome (ACS) and 1338 male controls.
Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles.
JCI Insight
October 2024
Department of Genetics.
BACKGROUNDTwo coding alleles within the APOL1 gene, G1 and G2, found almost exclusively in individuals genetically similar to West African populations, contribute substantially to the pathogenesis of chronic kidney disease (CKD). The APOL gene cluster on chromosome 22 contains a total of 6 APOL genes that have arisen as a result of gene duplication.METHODSUsing a genome-first approach in the Penn Medicine BioBank, we identified 62 protein-altering variants in the 6 APOL genes with a minor allele frequency of >0.
View Article and Find Full Text PDFSystematic Review of Genetic Modifiers Associated with the Development and/or Progression of Nephropathy in Patients with Sickle Cell Disease.
Int J Mol Sci
May 2024
Haematology Department, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Nnewi PMB 5025, Anambra State, Nigeria.
Sickle cell nephropathy (SCN) is a common complication of sickle cell disease (SCD) that significantly contributes to morbidity and mortality. In addition to clinical and life-style factors, genetic variants influence this risk. We performed a systematic review, searching five databases.
View Article and Find Full Text PDFGenetic ancestry, proportion of African ancestry, and apolipoprotein L1 risk variants in kidney recipients.
Am J Transplant
September 2024
Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!